Who is sponsoring NCT02308865?

NCT02308865 is sponsored by University Hospital, Lille.

What drugs are being tested in NCT02308865?

Interventions in NCT02308865: multi disciplinary palliative care monthly consultations.

What condition does NCT02308865 study?

NCT02308865 studies Lung Cancer Metastatic.

Is NCT02308865 still recruiting?

NCT02308865 is currently terminated. Last updated 11 July 2019.

Last reviewed 2019-07-11 · How we verify

NCT02308865: IMPAQ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Palliative Care in Metastatic Lung Cancer in Northern France

Terminated NA Last updated 11 July 2019

What this trial tests

NA trial testing multi disciplinary palliative care monthly consultations in Lung Cancer Metastatic in 71 participants. Terminated before completion.

Timeline

17 October 2014

Primary endpoint
23 February 2018

23 February 2018

Quick facts

Lead sponsor	University Hospital, Lille
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	71
Start date	17 October 2014
Primary completion	23 February 2018
Estimated completion	23 February 2018
Sites	1 location across France

Drugs / interventions tested

multi disciplinary palliative care monthly consultations

Conditions studied

Lung Cancer Metastatic — all drugs for Lung Cancer Metastatic →

Sponsor

University Hospital, Lille

Who can join

18 and older, any sex, with Lung Cancer Metastatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Early palliative care for adults with advanced cancer.
Haun MW, Estel S, Rücker G, Friederich HC, et al · · 2017 · cited 369× · PMID 28603881 · DOI 10.1002/14651858.cd011129.pub2
The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.
Bajwah S, Oluyase AO, Yi D, Gao W, et al · · 2020 · cited 133× · PMID 32996586 · DOI 10.1002/14651858.cd012780.pub2

Verify or expand the search:

Other recruiting trials for Lung Cancer Metastatic

Currently open trials in the same condition.

NCT07026110 — Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer · NA · recruiting
NCT06538012 — TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer · Phase 1, PHASE2 · recruiting
NCT05537922 — I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy · recruiting
NCT05452005 — Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer · Phase 1 · recruiting
NCT05419076 — A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain · Phase 2 · recruiting

Other University Hospital, Lille trials

Trials by the same sponsor.

NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02308865 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
Last refreshed: 11 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02308865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing